Who
Thomas William Burns
Chairman & CEO
Company insider
Files Form 4 as: Chairman & CEO, Glaukos; Director, Pulmonx; Director, Avedro.
In numbers
- Trades disclosed
- 350
- Buys
- 1
- Sells
- 47
- Bought
- $21K
- Sold
- $139.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 30 Jun 2015
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $579K4,059 at $142.57 | filing |
| 25 Jun 2026filed 29 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $579K4,059 at $142.57 | filing |
| 5 Jun 2026filed 9 Jun 2026 | LUNG PulmonxMedical Devices | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | LUNG PulmonxMedical Devices | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $271K2,469 at $109.60 | filing |
| 2 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $818K7,468 at $109.60 | filing |
| 2 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $271K2,469 at $109.60 | filing |
| 2 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code F | $818K7,468 at $109.60 | filing |
| 1 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —180,308 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —180,308 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —180,308 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code G | —180,308 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —9,380 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —14,184 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $358.5M18,933 at $18,933.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $358.5M18,933 at $18,933.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $12.2B110,254 at $110,254.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $9.7B98,474 at $98,474.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $12.2B110,254 at $110,254.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | $9.7B98,474 at $98,474.00 | filing |
News
Glaukos Expands Retinal Pipeline With RevOpsis Deal - Orange County Business JournalGKOS · ocbj.com · 19 Oct 2026Glaukos: IDose TR Plus Cataract Surgery Delivers Superior Eye Pressure Reduction In Phase 4 TrialGKOS · rttnews.com · 9 Oct 2026
0 headlines in the last 90 days name Thomas William Burns; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.